Per-Erik Sandlund new CEO of SwedenBIO
SwedenBIO has appointed Per-Erik Sandlund, former CEO of Amersham Biosciences, as new CEO. He will be succeding Dr. Hans Nyctelius who has recently been appointed as COO of Q-med, one of the largest biotech companies in northern Europe.
"SwedenBIO has, under the leadership of Dr Nyctelius, in a very short time established a strong support and today has about 110 member companies" says Björn Nilsson, chairman of SwedenBIO. "I want to thank Hans profoundly for this extraordinary achievement. Per-Erik Sandlund with his long industrial experience has the right expertise to take SwedenBIO to the next level."
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.